Leading the Dialogue: BioNJ Commentary & Perspectives on Patient, Policy & Industry Issues
Explore Publications from BioNJ on the Value of Medical Innovation
As the life sciences trade association for New Jersey, BioNJ is leading the conversation on policies impacting Patients and medical innovation in the Garden State and beyond. Through impactful publications in leading outlets, BioNJ sheds light on the issues affecting Patients, essential policy decisions, and key breakthroughs that make lifesaving advancements possible.
BioNJ is committed to elevating perspectives that promote greater affordability of treatments and foster medical innovation – Because Patients Can’t Wait®.
BioNJ encourages you to explore the articles below to learn more from our experts.
Leading the Dialogue: BioNJ Expert Commentary & Op-Eds
- Op-ed: How N.J. can help ensure U.S. stays ahead of China in medical innovation | BINJE
- Stronger Together: How Global Trade Powers U.S. Life Sciences & Protects Patients | ROI-NJ
- Price-Setting Policies: A Threat to Innovation & Patient Access | ROI-NJ
- 100% Drug Tariffs Are a Dire Threat — And Patients Can’t Wait | Life Science Leader
- Tariffs on Medicines Threaten Patients, Innovation and New Jersey’s Biopharma Leadership | BINJE
- From the Garden State to Global Health: Protecting U.S. Life Sciences Leadership | ROI-NJ
- Medicaid at Risk: Patients, Providers and the Impact of Proposed Cuts | NJBIZ
- Lawmakers need to act to fuel the engine driving research and improved outcomes for cancer Patients | ROI-NJ
